|
ASNSD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85673698638311E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6295853555448E-12 |
| Normal-vs-Stage2 |
1.75145999999904E-05 |
| Normal-vs-Stage3 |
8.780500E-03 |
| Normal-vs-Stage4 |
3.284200E-02 |
| Stage1-vs-Stage2 |
4.768400E-01 |
| Stage1-vs-Stage3 |
1.166380E-01 |
| Stage1-vs-Stage4 |
1.414620E-01 |
| Stage2-vs-Stage3 |
3.719400E-01 |
| Stage2-vs-Stage4 |
4.158000E-01 |
| Stage3-vs-Stage4 |
9.839200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98774330328888E-12 |
| Normal-vs-AfricanAmerican |
3.38799988064409E-10 |
| Normal-vs-Asian |
1.083900E-03 |
| Caucasian-vs-AfricanAmerican |
8.548600E-01 |
| Caucasian-vs-Asian |
7.893800E-01 |
| AfricanAmerican-vs-Asian |
7.366600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62581059726108E-12 |
| Normal-vs-Female |
2.214500E-04 |
| Male-vs-Female |
4.19190000000569E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.68337999999491E-05 |
| Normal-vs-Extreme_Weight |
1.62703184258817E-12 |
| Normal-vs-Obese |
2.90250046219853E-10 |
| Normal-vs-Extreme_Obese |
2.342600E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.499200E-01 |
| Normal_Weight-vs-Obese |
9.376800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.310600E-01 |
| Extreme_Weight-vs-Obese |
1.051830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.037800E-01 |
| Obese-vs-Extreme_Obese |
6.693200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.544400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.29379840174693E-11 |
| Normal-vs-Age(61-80Yrs) |
1.79856129989275E-14 |
| Normal-vs-Age(81-100Yrs) |
3.722600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.300250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.617800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.037200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.446160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.131600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.021000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.84297022087776E-14 |
| Normal-VS-Type2 PRCC |
2.60660004691715E-09 |
| Normal-VS-KIRP CIMP |
4.222600E-01 |
| Normal-VS-Unclassified PRCC |
3.19559999995001E-06 |
| Type1 PRCC-VS-Type2 PRCC |
5.797800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.021000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.791200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.703900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.550800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.345600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72628578098966E-12 |
| Normal-vs-N1 |
4.608200E-01 |
| Normal-vs-N2 |
1.030420E-04 |
| N0-vs-N1 |
4.780600E-03 |
| N0-vs-N2 |
8.188800E-01 |
| N1-vs-N2 |
1.225780E-02 |
|
|
